Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Metastatic Colorectal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04912258
What this trial is testing

Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 80
Not applicableUnknownNCT04684095
What this trial is testing

The Effect of ePRO on Quality of Life and Prognosis of Patients With Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticCancer
Harbin Medical University 338
Testing effectiveness (Phase 2)Looking for participantsNCT06282445
What this trial is testing

Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 36
Early research (Phase 1)Looking for participantsNCT06663319
What this trial is testing

JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

Who this might be right for
Colorectal NeoplasmsGastrointestinal Neoplasms
Janssen Research & Development, LLC 260
Testing effectiveness (Phase 2)Study completedNCT00819780
What this trial is testing

PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

Who this might be right for
Colon CancerColorectal CancerRectal Cancer+1 more
Amgen 285
Testing effectiveness (Phase 2)Study completedNCT01212718
What this trial is testing

Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate Synthase

Who this might be right for
Colorectal CancerNon Resectable MetastasisReference Lesion+2 more
University of Ulm 168
Not applicableUnknownNCT04131803
What this trial is testing

Probiotics Combined With Standard Chemotherapy Plus Targeted Therapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Unresectable Metastatic Colorectal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 140
Early research (Phase 1)Study completedNCT03087591
What this trial is testing

APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Solid NeoplasmRecurrent Colorectal Carcinoma+9 more
Wake Forest University Health Sciences 11
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Not applicableLooking for participantsNCT07377487
What this trial is testing

TheraSphere Japan Pre-Market Study

Who this might be right for
Liver Neoplasms
Boston Scientific Corporation 51
Testing effectiveness (Phase 2)WithdrawnNCT04001101
What this trial is testing

Anti-PD-1 +/- RT for MSI-H Solid Tumors

Who this might be right for
Microsatellite Instability HighMismatch Repair DeficiencyColorectal Cancer
University of Colorado, Denver
Testing effectiveness (Phase 2)Looking for participantsNCT05727163
What this trial is testing

FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients

Who this might be right for
Colorectal Cancer Metastatic
Sun Yat-sen University 194
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381309
What this trial is testing

Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM

Who this might be right for
CRCLiver Metastasis Colon Cancer
Jun Huang 114
Testing effectiveness (Phase 2)Active Not RecruitingNCT03493048
What this trial is testing

Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM

Who this might be right for
Colorectal CancerLiver Metastases
Sun Yat-sen University 146
Testing effectiveness (Phase 2)UnknownNCT06415851
What this trial is testing

Chemotherapy Plus Bevacizumab and Anti-PD-1 Followed by Induction Therapy of Chemotherapy Plus Bevacizumab

Who this might be right for
Metastatic Colorectal CancerMSS
Zhangfa Song 36
Early research (Phase 1)Looking for participantsNCT07066657
What this trial is testing

MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid TumorsColorectal CancerGastric Cancer+1 more
ArriVent BioPharma, Inc. 572
Early research (Phase 1)Looking for participantsNCT06440005
What this trial is testing

Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Who this might be right for
CancerAdvanced CancerLocally Advanced Carcinoma+8 more
Angiex, Inc. 80
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Testing effectiveness (Phase 2)Study completedNCT03647839
What this trial is testing

Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Australasian Gastro-Intestinal Trials Group 90
Not applicableStudy completedNCT04517643
What this trial is testing

TheraSphere® For Treatment of Metastases in Liver

Who this might be right for
Colorectal Cancer MetastaticColorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Next Page